Using Boot Camp Translation to Address Rural Disparities in Adolescent Vaccination
- Conditions
- Primary Prevention
- Interventions
- Behavioral: Boot Camp TranslationOther: Control
- Registration Number
- NCT03955757
- Lead Sponsor
- University of Colorado, Denver
- Brief Summary
The overall goal of this project is to implement the Boot Camp Translation process to develop a replicable approach for increasing adolescent vaccine uptake that can be adaptable and feasible to use in rural settings more broadly.
- Detailed Description
Boot Camp Translation (BCT) is a process to identify strategies that help communities improve health. It is a 6-month, facilitated, iterative community engagement process that brings together relevant stakeholders to develop and implement locally meaningful messages, materials, and strategies for health topics of interest.
This is a novel community engagement process that has a proven ability to result in meaningful and impactful strategies to improve compliance with recommended health behaviors in rural communities. The investigators will expand this work by testing BCT on its ability to improve vaccination with all recommend adolescent vaccines (Tdap, MenACWY, HPV, Flu).
The investigators will conduct a randomized, controlled trial in which 4 rural communities in Western Colorado will undergo BCT to develop and implement strategies to increase adolescent vaccination. Vaccination rates will be compared to 4 control communities that do not undergo BCT.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 6000
- Must live in one of the designated Colorado communities
- Does not live in one of the designated Colorado communities
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Boot Camp Translation Boot Camp Translation Intervention communities will undergo the Boot Camp Translation process. Control Control Control communities will behave as usual
- Primary Outcome Measures
Name Time Method Initiation of HPV vaccination series, 11-12 year olds Up to 24 months Percent of 11-12 year olds who have received \>=1 dose of the HPV vaccine by May 31,2021
- Secondary Outcome Measures
Name Time Method Completion of HPV vaccination series, 11-12 year olds Up to 24 months Percent of 11-12 year olds with \>=2 doses of the HPV vaccine by May 31,2021
Initiation of HPV vaccination series, 13-17 year olds Up to 24 months Percent of 13-17 year olds who have received \>=1 dose of the HPV vaccine by May 31,2021
Completion of HPV vaccination series, 13-17 year olds Up to 24 months Percent of 13-17 year olds who have completed the HPV vaccine series (2 or 3 doses, depending on age of initiation) by May 31,2021
Receipt of Tdap vaccine, 11-12 year olds Up to 24 months Percent of 11-12 year olds who have received Tdap vaccine by May 31,2021
Receipt of Tdap vaccine, 13-17 year olds Up to 24 months Percent of 13-17 year olds who have received Tdap vaccine by May 31,2021
Receipt of MCV vaccine, 11-12 year olds Up to 24 months Percent of 11-12 year olds who have received \>=1 dose of MCV vaccine by May 31,2021
Receipt of MCV vaccine, 13-17 year olds Up to 24 months Percent of 13-17 year olds who have received \>=1 dose of MCV vaccine by May 31,2021
Trial Locations
- Locations (1)
University of Colorado Anschutz Medical Campus
🇺🇸Aurora, Colorado, United States